VirTra reports record 2023 revenue $38.0M (+34% YoY); Q4 adj EBITDA corrected to $2.2M

VirTra, Inc

2024-Q1 EPS reported $0.11 revenue$747,977

FY 2023 revenue $38.0M (record, +34% YoY); net income $8.4M (from $2.0M); diluted EPS $0.77.
Q4 2023 revenue $10.1M (+17% YoY); net income $2.8M; diluted EPS $0.25; gross margin 83%.
FY 2023 adjusted EBITDA $11.6M (up from $4.0M); Q4 adj EBITDA corrected to $2.2M from $1.7M.
Backlog at year end $19.4M; new V-XR platform gaining traction; management expects continued growth in 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

VirTra, Inc reported the fourth quarter and year ended December 31, 2023 results: revenue $38.0 million, net income $8.4 million, EPS $0.77 per diluted share.

Period: the fourth quarter and year ended December 31, 2023
Revenue: $38.0 million
Net income: $8.4 million
EPS: $0.77 per diluted share
Result: reported results

Exact text from the filing

Total revenue increased 16% to $10.1 million from $8.7 million in the fourth quarter of 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

VirTra, Inc reported the fourth quarter and year ended December 31, 2023 results: revenue $38.0 million, net income $8.4 million, EPS $0.77 per diluted share.

Period: the fourth quarter and year ended December 31, 2023
Revenue: $38.0 million
Net income: $8.4 million
EPS: $0.77 per diluted share
Result: reported results

Exact text from the filing

Total revenue increased 34% to $38.0 million from $28.3 million in 2022.

View on SEC.gov

321 earnings releases filed in the last 30 days. Browse all earnings releases →

VirTra, Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-012612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.